The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential.
María N BarrachinaIrene IzquierdoLidia Hermida-NogueiraLuis A MoranAmparo PérezAna B ArroyoNuria García-BarberáRocío González-ConejeroSara TroitiñoJohannes A EbleJosé RiveraConstantino MartínezMaría I LozaEduardo DomínguezAngel GarciaPublished in: International journal of molecular sciences (2021)
Idelalisib may have antiplatelet effects with minor bleeding effects, which provides a rationale to evaluate its antithrombotic efficacy in humans.